Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Samuel Denmeade, MD
Johns Hopkins School of Medicine - Sidney Kimmel Comprehensive Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Unversity of Alabama
Birmingham, Alabama, United States
- City of Hope
Duarte, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
- Piedmont Cancer Institute
Atlanta, Georgia, United States
- University of Chicago
Chicago, Illinois, United States
- University of Kansas Cancer Center
Kansas City, Kansas, United States
- Tulane University Medical Center
New Orleans, Louisiana, United States
- Skccc at Johns Hopkins
Baltimore, Maryland, United States
- University of Maryland
Baltimore, Maryland, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Neraska Cancer Specialists
Omaha, Nebraska, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Allegheny Health Network
Pittsburgh, Pennsylvania, United States
- Huntsman Cancer Institute
Salt Lake City, Utah, United States
- University of Washing
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2015
- Primary completion
- 26 Oct 2018
- Completion
- 21 Feb 2020
- Last update posted
- 6 Nov 2020
- Registered enrollment
- 222
- Registry id
- NCT02286921
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.